2025-03-26 03:24:05
Latest Post
Rulka Electricals Secures 21 New Work Orders totaling Rs 12.36 Crore in March 2025
Ambo Agritec Ltd to expand presence in FMCG segment
Prism Johnson Ltd declared preferred bidder for mining lease of limestone block
Welspun Michigan Engineers Secures New Order to Upgrade the Haji Ali Storm Water Pumping Station in Mumbai
Capitalizing on Growth: Why Financial Services Firms Need a Unified AI Strategy
Stock Report
Ind-Swift Laboratories Ltd consolidated Q4FY24 PAT jumps to Rs. 233.82 crores
Posted On : 2024-05-14 21:03:49( TIMEZONE : IST )
Ind-Swift Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 418.5854 crores during the period ended March 31, 2024 as compared to Rs. 294.6282 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 238.8216 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 19.4188 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 40.42 for the period ended March 31, 2024 as compared to Rs. 3.29 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹ 418.5854 crs | ₹294.6282 crs |  42.07% |
| Net Profit | ₹238.8216 crs | ₹19.4188 crs | 1,129.85% |
| EPS | ₹40.42 | ₹3.29 | 1,128.57% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs. 418.5854 crores during the period ended March 31, 2024 as compared to Rs.314.4526 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.238.8216 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.-25.1235 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.40.42 for the period ended March 31, 2024 as compared to Rs.-4.25 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹ 418.5854 crs | ₹314.4526 crs | 33.12% |
| Net Profit | ₹238.8216 crs | ₹-25.1235 crs | 1,050.59% |
| EPS | ₹40.42 | ₹-4.25 | 1,051.06% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.1326.2674 crores during the Financial Year ended March 31, 2024 as compared to Rs.1240.8101 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.420.9616 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.47.5966 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.71.24 for the Financial Year ended March 31, 2024 as compared to Rs.8.06 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹1326.2674 crs | ₹1240.8101 crs | 6.89% |
| Net Profit | ₹420.9616 crs | ₹47.5966 crs | 784.44% |
| EPS | ₹71.24 | ₹8.06 | 783.87% |
Shares of Ind-Swift Laboratories Limited was last trading in BSE at Rs. 109.70 as compared to the previous close of Rs. 105.45. The total number of shares traded during the day was 418669 in over 3970 trades.
The stock hit an intraday high of Rs. 123.80 and intraday low of 109.10. The net turnover during the day was Rs. 49203442.00.
